Cell and Gene Outsourcing
-
Accelerating Your Gene Therapy: Not All Platforms Are Created Equal
Standardized methods, materials, and analytics are critical for overcoming hurdles in the gene therapy space. Explore how a platform approach to fast-track AAVs can enhance quality and efficiency.
-
Cryopreservation Best Practices For Cell & Gene Therapy Source Material
2/26/2024
Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.
-
Leveraging Platform Processes For Developing And Accelerating Novel Gene And Cancer Therapeutics
12/5/2024
Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.
-
An End-To-End Industrialization Roadmap For Autologous Cell Therapy
Explore specificities and challenges, leveraging automation for scalability with the Cocoon® Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.
-
De-Risk Your Path To Clinic With An AAV Suspension Platform
Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, PhD, Head of Viral Vectors Commercial Development.
-
Mastering The Art Of Developing A Successful Bispecific Antibody
10/3/2024
Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.